ADMA Biologics

ADMA Biologics is a New Jersey-based biopharmaceutical company that researches and develops plasma-derived products for the treatment of infectious diseases.

Business Model:

Revenue: $130.5M

Employees: 501-1,000

Rankings

Detailed ADMA Biologics Information

Geographic Data

ADMA Biologics headquarters map

Address: 465 Route 17 South

City: Ramsey

State: NJ

Zip: 07446

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$150M

Raised Total:

$298M

Metrics

2,072,622Website Global Rank

10,083Website Monthly Traffic

Twitter Followers

Description

ADMA Biologics is a New Jersey-based biopharmaceutical company that researches and develops plasma-derived products for the treatment of infectious diseases.

Contact Phone:
+12014785552

Contact Email:

ADMA Biologics went public on 10/18/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/18/2013

Ticker Symbol:
ADMA

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2022 Post-IPO Equity $60M
3/2015 Post-IPO Equity $10.3M
12/2014 Post-IPO Debt 1 $5M Hercules Capital
Hercules Capital
2/2014 Post-IPO Debt 1 $15M Hercules Capital
Hercules Capital
2/2012 Venture Round $0 Aisling Capital
Biomark Capital
Burrill &a; Company
Aisling Capital
Biomark Capital
Burrill &a; Company
11/2017 Post-IPO Equity $42M
6/2018 Post-IPO Equity $40M
10/2013 IPO -
5/2016 Post-IPO Debt 1 $4M Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
10/2017 Post-IPO Debt $0 Marathon Asset Management
Marathon Asset Management
Marathon Asset Management
Marathon Asset Management
1/2013 Debt Financing 1 $6M Hercules Capital
Hercules Capital
6/2015 Post-IPO Debt 1 $21M Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
Oxford Finance LLC
2/2019 Post-IPO Debt 1 $72.5M Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
3/2022 Post-IPO Debt $0 Hayfin Capital Management
Hayfin Capital Management
2/2020 Post-IPO Equity $82.3M
10/2021 Post-IPO Debt $57.5M
5/2019 Post-IPO Equity $51.8M
12/2022 Post-IPO Equity $69M
3/2022 Post-IPO Debt 1 $150M Hayfin Capital Management
Hayfin Capital Management
10/2013 IPO -
10/2017 Post-IPO Debt 1 $30M Marathon Asset Management
Marathon Asset Management
Marathon Asset Management
Marathon Asset Management
Announced Date Name Price
6/2017 Biotest - Therapy business

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research